Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 4.13M | $ 476K | 11.53% |
3/31/2025 | $ 6.25M | $ 898K | 14.37% |
12/31/2024 | $ 8.61M | $ 1.7M | 19.76% |
9/30/2024 | $ 13.59M | $ 915K | 6.73% |
6/30/2024 | $ 15.71M | $ 3.55M | 22.62% |
3/31/2024 | $ 16.19M | $ 3.29M | 20.35% |
12/31/2023 | $ 19.38M | $ 5.44M | 28.06% |
9/30/2023 | $ 27.86M | $ 15.26M | 54.79% |
6/30/2023 | $ 33.62M | $ 21.04M | 62.58% |
3/31/2023 | $ 37.46M | $ 23.39M | 62.45% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for AIM IMMUNOTECH INC is calculated as follows: CashnEq [ $ 38.5M ] / Assets [ $ 64.16M ]
(=) Cash to Assets [ 60% ]
Minimum
Sep 30, 2024
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |